Choosing between the BP and BN sequential strategies.

Diagnostic testing in clinical settings often involves multiple procedures to confirm or rule out conditions. Traditional approaches may apply all tests upfront, increasing costs and patient burden. A gap exists in determining when fewer tests, arranged strategically, could maintain accuracy while reducing resource use. Prior research has shown that sequential testing can improve efficiency, but the optimal strategy remains unclear. This uncertainty drives the need for a framework to evaluate when to use single tests versus sequential approaches. No prior work had resolved how test accuracy and cost interact with diagnostic strategy. The Youden Index has been used to measure test accuracy, but its application to sequential strategies is limited. Disease prevalence and test variability also influence diagnostic choices, yet their roles are not fully understood. This paper addresses these uncertainties by analyzing combinations of parameters to guide diagnostic strategy selection.

This study aimed to determine when single diagnostic tests or sequential testing strategies—specifically believe the positive (BP) and believe the negative (BN)—are most effective. The primary goal was to evaluate accuracy using the Youden Index as a key metric. The research sought to identify conditions under which BP or BN should be preferred over single tests. A secondary objective was to assess how test variability and disease prevalence affect diagnostic strategy selection. The study also examined cost implications when accuracy alone does not resolve the choice between strategies. Researchers focused on optimizing diagnostic accuracy while minimizing patient burden and costs. They analyzed parameter combinations to determine when sequential strategies are advantageous. The findings aim to provide clinicians with a decision-making framework for diagnostic testing.

The research employed a comparative analysis of single tests and two sequential strategies: BP and BN. Accuracy was measured using the Youden Index, which combines sensitivity and specificity. The study evaluated parameter combinations, including test accuracy, variability, and disease prevalence. A ratio of standard deviations (b) was used to assess test performance differences between diseased and non-diseased groups. Scenarios were grouped based on whether BP, BN, or single tests were optimal. Cost considerations were introduced when accuracy alone did not resolve the choice. The analysis used mathematical modeling to simulate diagnostic outcomes. Disease prevalence was varied to observe its impact on strategy preference. The study focused on identifying thresholds where one strategy outperforms another.

Approximately 75% of parameter combinations indicated a preference for either BP or BN based on higher accuracy. In roughly half of the scenarios, BP was favored, while the other half preferred BN. The ratio of standard deviations (b) strongly influenced the choice between strategies. Large b values for the first test in a sequence were associated with BN preference. Small b values tended to favor BP. When accuracy did not resolve the choice, cost was considered. Disease prevalence played a significant role in this context. Lower prevalence favored BN, while higher prevalence sometimes favored BP. The cost threshold for preferring a sequential strategy over a single test was often high. These findings suggest that while sequential strategies can improve accuracy, they are not always the best option.

The study concludes that BP and BN strategies are often preferred over single tests based on accuracy. However, the choice between BP and BN depends on the ratio of standard deviations (b) and disease prevalence. Large b values for the first test tend to favor BN, while small b values favor BP. When accuracy is insufficient to resolve the choice, cost and disease prevalence become important factors. Lower prevalence tends to favor BN, while higher prevalence may favor BP. The cost threshold for preferring sequential strategies is often high, suggesting that single tests may still be optimal in some cases. These findings align with the authors' claim that sequential strategies are not always superior. The study provides a framework for selecting diagnostic strategies based on specific parameters. It does not propose new diagnostic tests or universal recommendations.